SCHEMBL19420216

SCHEMBL19420216

CCCC(C)c1cc(Cl)ccc1OC

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 1/20 0.43
TAS1R3 Q7RTX0 2/20 0.42
TAS1R1 Q7RTX1 2/20 0.42
LMNA P02545 2/20 0.41
NPSR1 Q6W5P4 3/20 0.40
HTT P42858 1/20 0.40
PPARG P37231 1/20 0.40
RAB9A P51151 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
POLB P06746 1/20 0.39
LPAR1 Q92633 4/20 0.39
TTR P02766 1/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11292735 0.83 TTR (0.43) L3MBTL1ALDH1A1LMNANPSR1HTT
SCHEMBL22680775 0.83 ALDH1A1 (0.41) L3MBTL1ALDH1A1LMNANPSR1HTT
SCHEMBL16791810 0.82 ADRA2A (0.47) L3MBTL1ALDH1A1TAS1R3TAS1R1LMNA
SCHEMBL20868717 0.81 ALDH1A1 (0.44) L3MBTL1ALDH1A1LMNANPSR1HTT
SCHEMBL20868718 0.81 LMNA (0.42) L3MBTL1ALDH1A1LMNANPSR1HTT
SCHEMBL19389253 0.81 CYP2D6 (0.56) ALDH1A1LMNAHTTMEN1KMT2A
SCHEMBL22004342 0.79 TP53 (0.41) L3MBTL1ALDH1A1LMNANPSR1HTT
SCHEMBL84489 0.78 LPAR1 (0.50) ALDH1A1HTTMEN1KMT2APOLB
SCHEMBL24119872 0.77 GAA (0.41) L3MBTL1ALDH1A1LMNANPSR1HTT
SCHEMBL22932512 0.77 PSEN1 (0.37) L3MBTL1ALDH1A1LMNANPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170283397-A1 SUBSTITUTED 1-H-INDOL-3-YL-BENZAMIDE AND 1, 1'-BIPHENYL ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIV UTAH RES FOUND (US) 2017-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170283397-A1 SUBSTITUTED 1-H-INDOL-3-YL-BENZAMIDE AND 1, 1'-BIPHENYL ANALOGS AS HISTONE DEMETHYLASE INHIBITORS KDM1A, KDM1B, KDM3A L3MBTL1 240/4885ALDH1A1 456/4885TAS1R3 4423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.